Regeneron Pharmaceuticals, Inc. (REGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché REGN Giù? Forum Previsione

Perché le azioni Regeneron Pharmaceuticals, Inc. (REGN) sono in ribasso?

2023-06-27:

REGN's stock fell 8.71% following The Food and Drug Administration (FDA)'s rejection of an 8-milligram-dose version of Regeneron Pharmaceuticals' eye drug Eylea.

https://www.investors.com/news/technology/regn-stock-crumbles-after-the-fda-rejects-its-next-possible-blockbuster/?src=A00220

VRTX

$429.93

1.69%

MRNA

$125.67

7.13%

BNTX

$92.72

1.15%

ARGX

$359.48

4.04%

ALNY

$149.89

0.39%

Apri su Yahoo | Apri su Google | Aperto in Finviz

Regeneron Pharmaceuticals, Inc. (REGN)

Perché le azioni Regeneron Pharmaceuticals, Inc. (REGN) sono in ribasso?

Simile a REGN